CRDLNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31

Cardiol Therapeutics Inc.

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 40-F on Mar 31, 2026

$1.10+0.00 (0.00%)

Close on Oct 19, 2026

Cardiol Therapeutics Inc. revenue by segment

Cardiol Therapeutics does not break out revenue by segment, region or product in the tagged data of its filings for this period type.